IMAAVY™ is an FcRn blocker FDA-approved for patients 12 years of age and older living with anti-AChR or anti-MuSK antibody-positive generalized myasthenia gravis (gMG).1
Download Prescribing InformationView Press Release
Now Approved
AChR=acetylcholine receptor; FcRn=neonatal fragment crystallizable receptor; MuSK=muscle-specific tyrosine kinase.
Reference: 1. IMAAVYTM [Prescribing Information]. Horsham, PA:
Janssen Biotech, Inc.